Position in DMAC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,305,725
+$13,907 QoQ
Shares Held
327,518
-3.3% QoQ
Ownership
0.607%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 87 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,607,781 across 424 Biotechnology names. DMAC ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in DMAC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,305,725 | 327,518 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,291,818 | 338,526 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,591,192 | 325,527 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,332,898 | 339,578 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,265,697 | 324,538 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $671,891 | 177,280 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $978,442 | 180,192 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $504,013 | 120,290 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $355,146 | 120,389 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $354,057 | 127,819 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $379,517 | 133,633 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $231,425 | 89,700 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $354,931 | 82,160 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $138,961 | 90,825 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $147,056 | 93,068 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $111,914 | 90,254 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $205,441 | 101,704 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $249,855 | 99,942 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $377,784 | 101,283 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $343,135 | 85,570 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $379,117 | 85,195 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $777,987 | 85,026 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,226,828 | 120,989 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $495,091 | 116,767 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $664,385 | 95,871 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $34,902 | 12,465 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||